Butt, J. H., Dewan, P., Merkely, B., Belohlávek, J., Drożdż, J., Kitakaze, M., . . . Docherty, K. F. (2022). Efficacy and Safety of Dapagliflozin According to Frailty in Heart Failure With Reduced Ejection Fraction: A Post Hoc Analysis of the DAPA-HF Trial. Annals of Internal Medicine, 175(6), 820-831.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Butt, Jawad H., et al. "Efficacy and Safety of Dapagliflozin According to Frailty in Heart Failure With Reduced Ejection Fraction: A Post Hoc Analysis of the DAPA-HF Trial."
Annals of Internal Medicine 175, no. 6 (2022): 820-831.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Butt, Jawad H., et al. "Efficacy and Safety of Dapagliflozin According to Frailty in Heart Failure With Reduced Ejection Fraction: A Post Hoc Analysis of the DAPA-HF Trial."
Annals of Internal Medicine, vol. 175, no. 6, 2022, pp. 820-831.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.